Gilder Gagnon Howe & Co’s Outset Medical OM Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,454	Closed	-$2.39M	–	336
2021 Q4	$2.39M	Sell	3,454 -681	-16%	-$504K	0.01%	260
2021 Q3	$3.07M	Sell	4,135 -489	-11%	-$333K	0.02%	285
2021 Q2	$3.47M	Buy	4,624 +74	+2%	+$56.6K	0.02%	280
2021 Q1	$3.71M	Buy	4,550 +34	+0.8%	+$26.2K	0.02%	257
2020 Q4	$3.85M	Sell	4,516 -2,018	-31%	-$1.56M	0.02%	227
2020 Q3	$4.9M	Buy	+6,534	New	+$5.37M	0.03%	195

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Gilder Gagnon Howe & Co's OM Position: Q1 2022 in Review

Gilder Gagnon Howe & Co sold out of Outset Medical (OM) in Q1 2022, closing a stake of 3,454 shares — an estimated $2.39M sold.

Gilder Gagnon Howe & Co first reported a position in OM in Q3 2020 and held it in 6 quarters. The position peaked at $4.9M in Q3 2020. 152 funds tracked by Wall St. Rank hold OM as of Q1 2022.

Gilder Gagnon Howe & Co reported no remaining Outset Medical position as of Q1 2022 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 3,454 Outset Medical shares in Q1 2022, an estimated $2.39M.
Gilder Gagnon Howe & Co first reported a position in Outset Medical in Q3 2020 and held it in 6 quarters.
Gilder Gagnon Howe & Co's Outset Medical position peaked at $4.9M in Q3 2020.
152 funds tracked by Wall St. Rank held Outset Medical as of Q1 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2022, filed 16 May 2022.